Home Tags Artificial intelligence

Tag: Artificial intelligence

EMA-FDA joint principles for the use of AI along medicines lifecycle

staff -

EFPIA’s report on AI across the medicines lifecycle

staff -

EMA-HMA and MHRA plans on artificial intelligence

Manuele Cantù -

EMA’s position paper on AI in the pharmaceutical life cycle

Manuele Cantù -

FDA, a discussion paper on the use of AI

Manuele Cantù -

EuropaBio’s recommendations for biomanufacturing in the EU

Manuele Cantù -

EMA and HMA’s new joint regulatory strategy

Giuliana Miglierini -

Trends in APIs development for 2021

Giuliana Miglierini -

Regulatory sandboxes to experiment real-world innovation

Giuliana Miglierini -

The EU Commission published the new Pharmaceutical Strategy

Giuliana Miglierini -
12Page 1 of 2

Newsstand

  • Supplement to n.5 - October 2025 NCF International n.2 - 2025
  • NCF International n.1 - 2025
  • Supplemento to n.9 - October 2024 NCF International n.3 - 2024
Newsstand
© © 2026 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151